55
Views
28
CrossRef citations to date
0
Altmetric
Drug Evaluation

Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin’s lymphomas: a focus on FavId™

&
Pages 841-852 | Published online: 24 Nov 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Rajni Sinha, Pareen J Shenoy & Christopher R Flowers. (2008) Idiotype vaccine strategies for improving outcomes in follicular lymphoma. Expert Opinion on Biological Therapy 8:8, pages 1213-1223.
Read now
Christopher R Flowers. (2007) BiovaxID™ idiotype vaccination: active immunotherapy for follicular lymphoma. Expert Review of Vaccines 6:3, pages 307-317.
Read now
Seung-Tae Lee, Yun-Fang Jiang, Keon-Uk Park, Alison F Woo & Sattva S Neelapu. (2007) BiovaxID™: a personalized therapeutic cancer vaccine for non-Hodgkin’s lymphoma. Expert Opinion on Biological Therapy 7:1, pages 113-122.
Read now
Sattva S Neelapu, Seung-Tae Lee, Hong Qin, Soung-Chul Cha, Alison F Woo & Larry W Kwak. (2006) Therapeutic lymphoma vaccines: importance of T-cell immunity. Expert Review of Vaccines 5:3, pages 381-394.
Read now

Articles from other publishers (24)

Matthew J. Lin, Judit Svensson-Arvelund, Gabrielle S. Lubitz, Aurélien Marabelle, Ignacio Melero, Brian D. Brown & Joshua D. Brody. (2022) Cancer vaccines: the next immunotherapy frontier. Nature Cancer 3:8, pages 911-926.
Crossref
Xiao-Jun Wang, Jing Gao, Qin Yu, Min Zhang & Wei-Dong Hu. (2022) Multi-Omics Integration-Based Prioritisation of Competing Endogenous RNA Regulation Networks in Small Cell Lung Cancer: Molecular Characteristics and Drug Candidates. Frontiers in Oncology 12.
Crossref
Vera Ossendorf, Oliver Cornely, Andreas Draube, Ina Monsef, Andreas Engert & Nicole Skoetz. (2016) Idiotype vaccination for Non-Hodgkin lymphoma. Cochrane Database of Systematic Reviews.
Crossref
M.M. Soldevilla, A. Lopez-Diaz de Cerio, S. Inoges, F. Pastor, H. Villanueva & M. Bendandi. (2012) Anti-Idiotype Antibodies in Cancer Treatment. Journal of Cancer Research Updates 1:2, pages 153-161.
Crossref
Vera Ossendorf, Oliver Cornely, Andreas Draube, Ina Monsef, Andreas Engert & Nicole Skoetz. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
David J. Betting, Xi Y. Mu, Kamran Kafi, Desmond McDonnel, Francisco Rosas, Daniel P. Gold & John M. Timmerman. (2009) Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells. Vaccine 27:2, pages 250-259.
Crossref
Kamran Kafi, David J. Betting, Reiko E. Yamada, Michael Bacica, Kristopher K. Steward & John M. Timmerman. (2009) Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccines. Molecular Immunology 46:3, pages 448-456.
Crossref
David J. Betting, Kamran Kafi, Alireza Abdollahi-Fard, Sara A. Hurvitz & John M. Timmerman. (2008) Sulfhydryl-Based Tumor Antigen-Carrier Protein Conjugates Stimulate Superior Antitumor Immunity against B Cell Lymphomas. The Journal of Immunology 181:6, pages 4131-4140.
Crossref
Hyun Jun Park & Sattva S. Neelapu. (2008) Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials. British Journal of Haematology 142:2, pages 179-191.
Crossref
Paul Neeson, Zhen Kun Pan & Yvonne Paterson. (2007) Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma. Cancer Immunology, Immunotherapy 57:4, pages 493-505.
Crossref
Florentina Teofilovici & Kerry Wentworth. 2008. Cancer Vaccines: Challenges and Opportunities in Translation. Cancer Vaccines: Challenges and Opportunities in Translation 69 82 .
Lothar H. Finke, Kerry Wentworth, Brent Blumenstein, Natalie S. Rudolph, Hyam Levitsky & Axel Hoos. (2007) Lessons from randomized phase III studies with active cancer immunotherapies – Outcomes from the 2006 Meeting of the Cancer Vaccine Consortium (CVC). Vaccine 25, pages B97-B109.
Crossref
Sattva S. NeelapuBarry L. GauseLinda HarveySeung-Tae LeeAndrea Robin FryeJessie HortonRichard J. Robb, Mircea C. Popescu & Larry W. Kwak. (2007) A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma. Blood 109:12, pages 5160-5163.
Crossref
Mircea C. PopescuRichard J. RobbMichael M. BatenjanyLawrence T. BoniMary E. NevilleRobin W. PenningtonSattva S. Neelapu & Larry W. Kwak. (2007) A novel proteoliposomal vaccine elicits potent antitumor immunity in mice. Blood 109:12, pages 5407-5410.
Crossref
A López-Díaz de Cerio, N Zabalegui, M Rodríguez-Calvillo, S Inogés & M Bendandi. (2007) Anti-idiotype antibodies in cancer treatment. Oncogene 26:25, pages 3594-3602.
Crossref
Wen-Kai Weng, Debra Czerwinski & Ronald Levy. (2006) Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphoma patients regardless of their response to induction chemotherapy. Blood 109:3, pages 951-953.
Crossref
Jennifer H. Anolik, Jonathan W. Friedberg, Bo Zheng, Jennifer Barnard, Teresa Owen, Emily Cushing, Jennifer Kelly, Eric C.B. Milner, Richard I. Fisher & Iñaki Sanz. (2007) B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny. Clinical Immunology 122:2, pages 139-145.
Crossref
Seung-Tae LeeSattva S. NeelapuLarry W. Kwak. (2007) Therapeutic Vaccine for Lymphoma. Yonsei Medical Journal 48:1, pages 1.
Crossref
Sattva S. Neelapu & Larry W. Kwak. (2007) Vaccine Therapy for B-Cell Lymphomas: Next-Generation Strategies. Hematology 2007:1, pages 243-249.
Crossref
Lin Li, Shiphali Gupta, Tayyaba Bashir, Prasad R. Koduru, Judith Brody & Steven L. Allen. (2006) Serial cytogenetic alterations resulting in transformation of a low-grade follicular lymphoma to Burkitt lymphoma. Cancer Genetics and Cytogenetics 170:2, pages 140-146.
Crossref
Charles H. Redfern, Troy H. Guthrie, Alberto Bessudo, John J. Densmore, Peter R. Holman, Nalini Janakiraman, John P. Leonard, Richard L. Levy, Richard G. Just, Mitchell R. Smith, Fred P. Rosenfelt, Peter H. Wiernik, William D. Carter, Daniel P. Gold, Teresa J. Melink, John C. Gutheil & John F. Bender. (2006) Phase II Trial of Idiotype Vaccination in Previously Treated Patients With Indolent Non-Hodgkin’s Lymphoma Resulting in Durable Clinical Responses. Journal of Clinical Oncology 24:19, pages 3107-3112.
Crossref
Vikas Aurora & Jane N. Winter. (2006) Current controversies in follicular lymphoma. Blood Reviews 20:4, pages 179-200.
Crossref
Julie M Vose. (2006) Personalized immunotherapy for the treatment of non‐Hodgkin's lymphoma: a promising approach. Hematological Oncology 24:2, pages 47-55.
Crossref
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 23:3-4, pages 136-143.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.